2025 ICD-10-CM Diagnosis Code C96.22

Mast cell sarcoma

C96.22 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2025 edition of ICD-10-CM C96.22 became effective on October 1, 2024.
This is the American ICD-10-CM version of C96.22 – other international versions of ICD-10 C96.22 may differ.

The following code(s) above C96.22 contain annotation back-references

that may be applicable to C96.22:

C00-D49 Neoplasms
C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
C96 Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
C96.2 Malignant mast cell neoplasm

ICD-10-CM C96.22 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
820 Lymphoma and leukemia with major o.r. Procedures with mcc
821 Lymphoma and leukemia with major o.r. Procedures with cc
822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
823 Lymphoma and non-acute leukemia with other procedures with mcc
824 Lymphoma and non-acute leukemia with other procedures with cc
825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
840 Lymphoma and non-acute leukemia with mcc
841 Lymphoma and non-acute leukemia with cc
842 Lymphoma and non-acute leukemia without cc/mcc

Convert C96.22 to ICD-9-CMCode History

2018 (effective 10/1/2017): New code
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change
2024 (effective 10/1/2023): No change
2025 (effective 10/1/2024): No change

Code annotations containing back-references to C96.22:

Diagnosis Index entries containing back-references to C96.22: